CPT 0571U: LiquidHALLMARK® ctDNA/ctRNA NGS 80-gene Panel
CPT code 0571U is a Proprietary Laboratory Analyses (PLA) code that reports LiquidHALLMARK® testing by Lucence Health Inc., a blood-based next-generation sequencing (NGS) assay that evaluates 80 genes from circulating tumor DNA (ctDNA) and 10 genes from circulating tumor RNA (ctRNA) to identify clinically actionable genetic variants relevant to cancer treatment decisions; service type: NGS-based comprehensive ctDNA/ctRNA molecular profiling, typical site of service: outpatient blood draw or clinical laboratory processing.
Customize your policy alerts
Sign up for cpt 0571U policy alerts
Get alerted when payer policies referencing 0571U are released or updated.
Monitor payer policy activity